Global Compounding Pharmacy Market With An Average Growth Rate Of 2.98% During 2013 To 2017
Warning: date() expects parameter 2 to be long, string given in /www/wwwroot/www.globalinforesearch.com/static/themes/default/info_detail.php on line 32
In the last several years, Global market of Compounding Pharmacy developed stable, with an average growth rate of 2.98% during 2013 to 2017. In 2017, Global Revenue of Compounding Pharmacy is nearly 10314 M USD, and will continual growth at 2.78% in 2025 the revenue will at 12820 M USD
The classification of Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2017 is about 34%.
Compounding Pharmacy is widely used for consumers aged 18 and younger, consumers aged 19 to 44, consumers aged 45 to 64, consumers aged 65 and older. The most proportion of compounding pharmacy is consumers aged 45 to 64, and the proportion in 2017 is 40.7%.
North America is the largest market for compounding pharmacy, with a market share nearly 57% in 2017. Following North America, Europe is the second largest market with the consumption market share of 25%.
Market competition is not intense Fagron, Wedgewood Pharma, CAPS, Fresenius Kabi, Advanced Pharma, PharMEDium Services are the leaders of the industry, with high-end customers in the industry.